Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction

BACKGROUND: This study aimed to investigate intracoronary nicorandil treatment on the no-reflow phenomenon (NRP) during primary percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) and to compare nicorandil with sodium nitroprusside. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Qi, Niu, Jinghui, Chen, Tao, Yin, Hongshan, Wang, Tao, Jiang, Zhian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954842/
https://www.ncbi.nlm.nih.gov/pubmed/29726480
http://dx.doi.org/10.12659/MSM.906815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954842/
https://www.ncbi.nlm.nih.gov/pubmed/29726480
http://dx.doi.org/10.12659/MSM.906815

Ejemplares similares